[go: up one dir, main page]

WO1988007869A3 - ANTICORPS ANTI-INTERFERON gamma ET LEUR APPLICATION THERAPEUTIQUE - Google Patents

ANTICORPS ANTI-INTERFERON gamma ET LEUR APPLICATION THERAPEUTIQUE Download PDF

Info

Publication number
WO1988007869A3
WO1988007869A3 PCT/BE1988/000011 BE8800011W WO8807869A3 WO 1988007869 A3 WO1988007869 A3 WO 1988007869A3 BE 8800011 W BE8800011 W BE 8800011W WO 8807869 A3 WO8807869 A3 WO 8807869A3
Authority
WO
WIPO (PCT)
Prior art keywords
gamma
interferon
antibodies
therapeutic application
immunoglobulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/BE1988/000011
Other languages
English (en)
Other versions
WO1988007869A2 (fr
Inventor
Alfons Josef Denis Ali Billiau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stichting Rega VZW
Original Assignee
Stichting Rega VZW
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Rega VZW filed Critical Stichting Rega VZW
Publication of WO1988007869A2 publication Critical patent/WO1988007869A2/fr
Publication of WO1988007869A3 publication Critical patent/WO1988007869A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Immunoglobuline ayant une activité d'anticorps neutralisant dressée contre l'interféron gamma se trouvant chez l'homme et l'animal, destinée à être utilisée à titre d'agent thérapeutique, de substance active pour inhiber des réactions inflammatoires, empêcher ou inhiber la malaria cérébrale, et comme préparation médicale ou vétérinaire comprenant un excipient acceptable d'immunoglobuline.
PCT/BE1988/000011 1987-04-16 1988-04-18 ANTICORPS ANTI-INTERFERON gamma ET LEUR APPLICATION THERAPEUTIQUE Ceased WO1988007869A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8700927A NL8700927A (nl) 1987-04-16 1987-04-16 Anti-interferon-gamma-antilichamen; en hun therapeutische toepassing.
NL8700927 1987-04-16

Publications (2)

Publication Number Publication Date
WO1988007869A2 WO1988007869A2 (fr) 1988-10-20
WO1988007869A3 true WO1988007869A3 (fr) 1988-11-17

Family

ID=19849883

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BE1988/000011 Ceased WO1988007869A2 (fr) 1987-04-16 1988-04-18 ANTICORPS ANTI-INTERFERON gamma ET LEUR APPLICATION THERAPEUTIQUE

Country Status (2)

Country Link
NL (1) NL8700927A (fr)
WO (1) WO1988007869A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
GB8905400D0 (en) * 1989-03-09 1989-04-19 Jonker Margreet Medicaments
DK195089A (da) * 1989-04-20 1990-10-21 Morten Bagge Hansen Regulatoriske proteiner
IT1231727B (it) * 1989-08-11 1991-12-21 Enrico Savoldi Peptidi utili per la determinazione e la purificazione di anticorpi anti gamma interferone.
DK96493D0 (da) * 1993-08-26 1993-08-26 Mouritsen Og Elsner Aps Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden
US20020025316A1 (en) 1995-08-18 2002-02-28 Ferguson Mark Williams James Pharmaceutical composition containing inhibitors of interferon-gamma
GB2304342A (en) * 1995-08-18 1997-03-19 Univ Manchester Pharmaceutical comprising either an inhibitor or a stimulator of interferon gamma
ATE305506T1 (de) 1998-12-09 2005-10-15 Protein Design Labs Inc Verwendung von il-12 antikörpern zur behandlung von psoriasis
US7335743B2 (en) 2002-10-16 2008-02-26 Amgen Inc. Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitors

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0088540A2 (fr) * 1982-02-22 1983-09-14 Biogen, Inc. Séquences d'ADN, molécules d'ADN recombinant et procédure pour la production de polypeptides semblables à l'interféron humain immun

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0088540A2 (fr) * 1982-02-22 1983-09-14 Biogen, Inc. Séquences d'ADN, molécules d'ADN recombinant et procédure pour la production de polypeptides semblables à l'interféron humain immun

Also Published As

Publication number Publication date
NL8700927A (nl) 1988-11-16
WO1988007869A2 (fr) 1988-10-20

Similar Documents

Publication Publication Date Title
IT8467767A0 (it) Preparati farmaceutici ad attivita antimicrobica e procedimento per laloro preparazione
GR3015241T3 (en) Pesticidal system.
NO882406D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive urinstoff- og karbamat-forbindelser.
NO884154D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive preparater.
CA2291144A1 (fr) Traitement topique du psoriasis mettant en oeuvre des anticorps aptes a neutraliser il-8
WO1988007869A3 (fr) ANTICORPS ANTI-INTERFERON gamma ET LEUR APPLICATION THERAPEUTIQUE
FI961282L (fi) Transdermaalinen terapeuttinen systeemi, jossa on asetyylisalisyylihappo vaikuttavana aineena
ES478967A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
EP0019403A3 (en) Hydroxyalkyl-starch drug carrier and method of administering a biologically active compound to an animal
IT1178044B (it) Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina
DE3164719D1 (en) Drugs with cytostatic activity, derivatives of isocyanuric acid and process for their preparation
AU3401093A (en) Therapeutic agent for threatened abortion
ZA845682B (en) Benzamidine derivatives having an antimicrobial activity process for their preparation and use as disinfectant drugs or preservatives
AU591017B2 (en) Human monoclonal antibody and drug for prophylaxis and treatment of infectious diseases comprising same as effective ingredient
DK0659341T3 (da) Fast insecticidt præparat
NO304518B1 (no) Benzimidazoler, anvendelse derav for fremstilling av et medikament, samt farmas°ytiske preparater som omfatter dem
AU2366388A (en) A method for the preparation of a pharmaceutical curative for the veterinary and humane medicine, with antiviral and antitumoral effect
BR9710629A (pt) Composi-Æo farmac-utica processo para sua prepara-Æo composto para utiliza-Æo como agente terap-utico e utiliza-Æo e utiliza-Æo de um composto
HK64993A (en) Therapeutic agent for the treatment of disorders associated with cerebral ischemia
Kamat Effects of small doses of anticholinergic agent on EEG auditory evoked responses and behavior of cats.
AU1370188A (en) Tert.-butylamino-3-(phenyl-2'-phenoxy)-1-propanol-2 and its acid addition salts for use as an active therapeutic substance
UA26326C2 (uk) Спосіб лікуваhhя захворюваhь вірусhої та бактеріальhої етіології у людиhи і твариhи та композиція для його реалізації
NO880495L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 1-dethia-2-thia-cefalosporinsyrederivater.
NO890742L (no) Farmasoeytisk preparat som sikrer den transdermale absorpsjon av aktiv bestanddel, og fremgangsmaate for fremstillingav dette.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE BJ CF CG CH CM DE FR GA GB IT LU ML MR NL SE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE BJ CF CG CH CM DE FR GA GB IT LU ML MR NL SE SN TD TG